Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Hims & Hers posts $753M in Q2 revenue as it preps for push into peptide market
Digital health and wellness company Hims & Hers is ready to tap into a multi-billion dollar peptide market if U.S. regulators loosen restrictions on manufacturing. | Digital health and wellness company Hims & Hers is ready to tap into a multi-billion peptide market if U.S. regulators loosen restrictions on manufacturing.
TL;DRAI
Hims & Hers posted $753M Q2 revenue (+38% YoY) and acquired a U.S. peptide facility to launch approved peptides by year-end. The $2.2-3.3B peptide market diversifies compounding revenue, but Q2's $86M loss versus $43M YoY profit signals integration drag and runway pressure.
1,754 words~8 min read
